• Home
  • Study Details
By physician referral or invitation only

Atrial Fibrillation Study

The OCEANIC-AF Study is evaluating an investigational anticoagulant medication to see if it may safely and effectively reduce the likelihood of blood clots and stroke in patients with atrial fibrillation who are at risk for stroke.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Anil Gehi
Medicine - Cardiology

Study Type

Clinical or Medical
Interventional

Study Topics

Heart and Circulation

IRB Number

22-2843

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research